Bio Medicine resources:

The Group's principal activity is to own and license the N-Viro Processes, patented technologies to treat and recycle wastewater and other bio-organic wastes utilizing certain alkaline and mineral by-products produced by the cement, lime, electric utilities and other industries. It operates in four segments:The single most critical cost component to every beneficial use option is the ability to get as much water out of the biosolids as possible in the dewatering process.
The N-Viro process can receive biosolids as low as 12% solids, however, the higher the solids the better. Dependent upon facility design biosolids can be received directly from dewatering into the processor, tipped onto a receiving floor, or delivered into a receiving bin. A key aspect regarding receiving is the process allows for a wide spot in the line which allows operators to run the equipment automatically which enables more time to focus on the efficiencies of dewatering.http://www.nviro.com
An investment into state-of-the-art dewatering equipment is always worth the analysis. Management Operations provides employee and management services to operate the Toledo Ohio Wastewater Treatment Facility and the Daytona/Volusia County Florida Treatment Facility.Other Domestic Operations includes sales of territory or site licenses and royalty fees to use N-Viro technology in the United States. Foreign Operations includes sale of territory or site licenses and royalty fees to use N-Viro technology in foreign operations. Research and Development, the Group contracts with Federal and State agencies to perform or assist in research and development on the Group's technology